The global Graft Versus Host Disease (GvHD) market size is estimated to be $1.89 billion in 2023, and MAResearch analysts predict it will reach $3.7 billion by 2032, growing at a CAGR of 7.9% during the forecast period from 2024 to 2032.
The USA market for Global Graft Versus Host Disease (GvHD) market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Graft Versus Host Disease (GvHD) market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Graft Versus Host Disease (GvHD) market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
This report studies the Graft Versus Host Disease (GvHD) market, covering market size for segment by type (Monoclonal Antibodies, mTOR Inhibitors, etc.), by application (Hospital Pharmacies, Retail Pharmacies, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Pfizer, Incyte Corporation, Bristol-Myers Squibb, AbbVie, Sanofi (Genzyme), etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).
This report provides detailed historical analysis of global market for Graft Versus Host Disease (GvHD) from 2018-2023, and provides extensive market forecasts from 2024-2032 by region/country and subsectors. It covers the sales/revenue/value, gross margin, historical growth and future perspectives in the Graft Versus Host Disease (GvHD) market.
Leading Players of Graft Versus Host Disease (GvHD) including:
- Pfizer
- Incyte Corporation
- Bristol-Myers Squibb
- AbbVie
- Sanofi (Genzyme)
- Astellas Pharma
- Roche
- Genentech
- Kadmon Pharmaceuticals
- Merck
- Novartis
- Neovii Biotech
- Soligenix
- Mesoblast
- Takeda Pharmaceutical
Market split by Type:
- Monoclonal Antibodies
- mTOR Inhibitors
- Tyrosine Kinase Inhibitors
- Thalidomide
- Etanercept
Market split by Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Market split by Sales Channel:
- Direct Channel
- Distribution Channel
Market split by Region/Country:
- North America (United States and Canada)
- Europe (Germany, UK, France, Italy, Spain, and Russia, etc.)
- Asia-Pacific (China, Japan, Korea, India, Australia, and Southeast Asia, etc.)
- South America (Brazil, Mexico, and Argentina, etc.)
- Middle East & Africa (Turkey, UAE, Saudi Arabia, and South Africa, etc.)
If you have any special requirements, please let us know and we can provide you the customized report as you want.
TABLE OF CONTENTS
Table of Contents
Chapter 1 Graft Versus Host Disease (GvHD) Market Overview
1.1 Graft Versus Host Disease (GvHD) Definition
1.2 Global Graft Versus Host Disease (GvHD) Market Size Status and Outlook (2018-2032)
1.3 Global Graft Versus Host Disease (GvHD) Market Size Comparison by Region (2018-2032)
1.4 Global Graft Versus Host Disease (GvHD) Market Size Comparison by Type (2018-2032)
1.5 Global Graft Versus Host Disease (GvHD) Market Size Comparison by Application (2018-2032)
1.6 Global Graft Versus Host Disease (GvHD) Market Size Comparison by Sales Channel (2018-2032)
1.7 Graft Versus Host Disease (GvHD) Market Dynamics
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Merger/Acquisition/Expansion)
1.7.4 Key Trends in Graft Versus Host Disease (GvHD) Market
Chapter 2 Graft Versus Host Disease (GvHD) Market Competition by Player
2.1 Global Graft Versus Host Disease (GvHD) Sales and Market Share by Player (2021-2023)
2.2 Global Graft Versus Host Disease (GvHD) Revenue and Market Share by Player (2021-2023)
2.3 Global Graft Versus Host Disease (GvHD) Average Price by Player (2021-2023)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Graft Versus Host Disease (GvHD) Market Segment by Type
3.1 Global Graft Versus Host Disease (GvHD) Market by Type
3.1.1 Monoclonal Antibodies
3.1.2 mTOR Inhibitors
3.1.3 Tyrosine Kinase Inhibitors
3.1.4 Thalidomide
3.1.5 Etanercept
3.2 Global Graft Versus Host Disease (GvHD) Sales and Market Share by Type (2018-2023)
3.3 Global Graft Versus Host Disease (GvHD) Revenue and Market Share by Type (2018-2023)
3.4 Global Graft Versus Host Disease (GvHD) Average Price by Type (2018-2023)
3.5 Conclusion of Segment by Type
Chapter 4 Graft Versus Host Disease (GvHD) Market Segment by Application
4.1 Global Graft Versus Host Disease (GvHD) Market by Application
4.1.1 Hospital Pharmacies
4.1.2 Retail Pharmacies
4.1.3 Online Pharmacies
4.2 Global Graft Versus Host Disease (GvHD) Revenue and Market Share by Application (2018-2023)
4.3 Conclusion of Segment by Application
Chapter 5 Graft Versus Host Disease (GvHD) Market Segment by Sales Channel
5.1 Global Graft Versus Host Disease (GvHD) Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global Graft Versus Host Disease (GvHD) Revenue and Market Share by Sales Channel (2018-2023)
5.3 Conclusion of Segment by Sales Channel
Chapter 6 Graft Versus Host Disease (GvHD) Market Segment by Region & Country
6.1 Global Graft Versus Host Disease (GvHD) Market Size and CAGR by Region (2018-2032)
6.2 Global Graft Versus Host Disease (GvHD) Sales and Market Share by Region (2018-2023)
6.3 Global Graft Versus Host Disease (GvHD) Revenue and Market Share by Region (2018-2023)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Graft Versus Host Disease (GvHD) Market Share by Type
6.4.3 North America Graft Versus Host Disease (GvHD) Market Share by Application
6.4.4 United States
6.4.5 Canada
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Graft Versus Host Disease (GvHD) Market Share by Type
6.5.3 Europe Graft Versus Host Disease (GvHD) Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Spain
6.5.9 Russia
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Graft Versus Host Disease (GvHD) Market Share by Type
6.6.3 Asia-Pacific Graft Versus Host Disease (GvHD) Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Graft Versus Host Disease (GvHD) Market Share by Type
6.7.3 South America Graft Versus Host Disease (GvHD) Market Share by Application
6.7.4 Brazil
6.7.5 Mexico
6.7.6 Argentina
6.7.7 Colombia
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Graft Versus Host Disease (GvHD) Market Share by Type
6.8.3 Middle East & Africa Graft Versus Host Disease (GvHD) Market Share by Application
6.8.4 Turkey
6.8.5 UAE
6.8.6 Saudi Arabia
6.8.7 South Africa
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Graft Versus Host Disease (GvHD) Players
7.1 Pfizer
7.1.1 Company Snapshot
7.1.2 Product/Service Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.2 Incyte Corporation
7.3 Bristol-Myers Squibb
7.4 AbbVie
7.5 Sanofi (Genzyme)
7.6 Astellas Pharma
7.7 Roche
7.8 Genentech
7.9 Kadmon Pharmaceuticals
7.10 Merck
7.11 Novartis
7.12 Neovii Biotech
7.13 Soligenix
7.14 Mesoblast
7.15 Takeda Pharmaceutical
Chapter 8 Upstream and Downstream Analysis of Graft Versus Host Disease (GvHD)
8.1 Industrial Chain of Graft Versus Host Disease (GvHD)
8.2 Upstream of Graft Versus Host Disease (GvHD)
8.3 Downstream of Graft Versus Host Disease (GvHD)
Chapter 9 Development Trend of Graft Versus Host Disease (GvHD) (2024-2032)
9.1 Global Graft Versus Host Disease (GvHD) Market Size (Sales and Revenue) Forecast (2024-2032)
9.2 Global Graft Versus Host Disease (GvHD) Market Size and CAGR Forecast by Region (2024-2032)
9.3 Global Graft Versus Host Disease (GvHD) Market Size and CAGR Forecast by Type (2024-2032)
9.4 Global Graft Versus Host Disease (GvHD) Market Size and CAGR Forecast by Application (2024-2032)
9.5 Global Graft Versus Host Disease (GvHD) Market Size and CAGR Forecast by Sales Channel (2024-2032)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification
LIST OF TABLES & FIGURES
List of Tables and Figures
Figure Graft Versus Host Disease (GvHD) Example
Figure Global Graft Versus Host Disease (GvHD) Revenue (Million $) Status and Outlook (2018-2032)
Figure Global Graft Versus Host Disease (GvHD) Revenue (Million $) Comparison by Region (2018-2032)
Figure Global Graft Versus Host Disease (GvHD) Revenue (Million $) Comparison by Type (2018-2032)
Figure Global Graft Versus Host Disease (GvHD) Revenue (Million $) Comparison by Application (2018-2032)
Figure Global Graft Versus Host Disease (GvHD) Revenue (Million $) Comparison by Sales Channel (2018-2032)
Table Global Graft Versus Host Disease (GvHD) Sales by Player (2021-2023)
Table Global Graft Versus Host Disease (GvHD) Sales Market Share by Player (2021-2023)
Figure Global Graft Versus Host Disease (GvHD) Sales Market Share by Player in 2023
Table Global Graft Versus Host Disease (GvHD) Revenue (Million $) by Player (2021-2023)
Table Global Graft Versus Host Disease (GvHD) Revenue Market Share by Player (2021-2023)
Figure Global Graft Versus Host Disease (GvHD) Revenue Market Share by Player in 2023
Table Global Graft Versus Host Disease (GvHD) Average Price by Player (2021-2023)
Figure Global Graft Versus Host Disease (GvHD) Average Price by Player in 2023
Figure Global Graft Versus Host Disease (GvHD) Players Competition Situation ? Top 5 Players? Revenue Market Share in 2021
Figure Global Graft Versus Host Disease (GvHD) Players Competition Trends ? Top 5 Players? Revenue Market Share in 2023
Figure Example of Monoclonal Antibodies
Figure Global Monoclonal Antibodies Revenue (Million $) and Growth Rate (2018-2023)
Figure Example of mTOR Inhibitors
Figure Global mTOR Inhibitors Revenue (Million $) and Growth Rate (2018-2023)
Figure Example of Tyrosine Kinase Inhibitors
Figure Global Tyrosine Kinase Inhibitors Revenue (Million $) and Growth Rate (2018-2023)
Figure Example of Thalidomide
Figure Global Thalidomide Revenue (Million $) and Growth Rate (2018-2023)
Figure Example of Etanercept
Figure Global Etanercept Revenue (Million $) and Growth Rate (2018-2023)
Table Global Graft Versus Host Disease (GvHD) Sales by Type (2018-2023)
Table Global Graft Versus Host Disease (GvHD) Sales Market Share by Type (2018-2023)
Figure Global Graft Versus Host Disease (GvHD) Sales Market Share by Type in 2023
Table Global Graft Versus Host Disease (GvHD) Revenue (Million $) by Type (2018-2023)
Table Global Graft Versus Host Disease (GvHD) Revenue Market Share by Type (2018-2023)
Figure Global Graft Versus Host Disease (GvHD) Revenue Market Share by Type in 2023
Table Global Graft Versus Host Disease (GvHD) Average Price by Type (2018-2023)
Figure Global Graft Versus Host Disease (GvHD) Average Price by Type in 2023
Table Leading Players of Graft Versus Host Disease (GvHD) by Type in 2023
Figure Example of Hospital Pharmacies
Figure Global Graft Versus Host Disease (GvHD) for Hospital Pharmacies Revenue (Million $) and Growth Rate (2018-2023)
Figure Example of Retail Pharmacies
Figure Global Graft Versus Host Disease (GvHD) for Retail Pharmacies Revenue (Million $) and Growth Rate (2018-2023)
Figure Example of Online Pharmacies
Figure Global Graft Versus Host Disease (GvHD) for Online Pharmacies Revenue (Million $) and Growth Rate (2018-2023)
Table Global Graft Versus Host Disease (GvHD) Sales by Application (2018-2023)
Table Global Graft Versus Host Disease (GvHD) Sales Market Share by Application (2018-2023)
Figure Global Graft Versus Host Disease (GvHD) Sales Market Share by Application in 2023
Table Leading Consumers of Graft Versus Host Disease (GvHD) by Application in 2023
Figure Example of Direct Channel
Figure Global Graft Versus Host Disease (GvHD) for Direct Channel Revenue (Million $) and Growth Rate (2018-2023)
Figure Example of Distribution Channel
Figure Global Graft Versus Host Disease (GvHD) for Distribution Channel Revenue (Million $) and Growth Rate (2018-2023)
Table Global Graft Versus Host Disease (GvHD) Revenue by Sales Channel (2018-2023)
Table Global Graft Versus Host Disease (GvHD) Revenue Market Share by Sales Channel (2018-2023)
Figure Global Graft Versus Host Disease (GvHD) Revenue Market Share by Sales Channel in 2023
Table Leading Distributors/Dealers of Graft Versus Host Disease (GvHD) by Sales Channel in 2023
Table Global Graft Versus Host Disease (GvHD) Market Size and CAGR by Region (2018-2032)
Table Global Graft Versus Host Disease (GvHD) Sales by Region (2018-2023)
Table Global Graft Versus Host Disease (GvHD) Sales Market Share by Region (2018-2023)
Figure Global Graft Versus Host Disease (GvHD) Sales Market Share by Region in 2023
Table Global Graft Versus Host Disease (GvHD) Revenue (Million $) by Region (2018-2023)
Table Global Graft Versus Host Disease (GvHD) Revenue Market Share by Region (2018-2023)
Figure Global Graft Versus Host Disease (GvHD) Revenue Market Share by Region in 2023
Table North America Graft Versus Host Disease (GvHD) Sales by Country (2018-2023)
Figure North America Graft Versus Host Disease (GvHD) Sales Market Share by Country (2018-2023)
Table North America Graft Versus Host Disease (GvHD) Revenue by Country (2018-2023)
Figure North America Graft Versus Host Disease (GvHD) Revenue Market Share by Country (2018-2023)
Figure North America Graft Versus Host Disease (GvHD) Market Share by Type in 2023
Figure North America Graft Versus Host Disease (GvHD) Market Share by Application in 2023
Figure United States Graft Versus Host Disease (GvHD) Sales and Growth Rate (2018-2023)
Figure United States Graft Versus Host Disease (GvHD) Revenue (Million $) and Growth Rate (2018-2023)
Figure Canada Graft Versus Host Disease (GvHD) Sales and Growth Rate (2018-2023)
Figure Canada Graft Versus Host Disease (GvHD) Revenue (Million $) and Growth Rate (2018-2023)
Table Europe Graft Versus Host Disease (GvHD) Sales by Country (2018-2023)
Figure Europe Graft Versus Host Disease (GvHD) Sales Market Share by Country (2018-2023)
Table Europe Graft Versus Host Disease (GvHD) Revenue by Country (2018-2023)
Figure Europe Graft Versus Host Disease (GvHD) Revenue Market Share by Country (2018-2023)
Figure Europe Graft Versus Host Disease (GvHD) Market Share by Type in 2023
Figure Europe Graft Versus Host Disease (GvHD) Market Share by Application in 2023
Figure Germany Graft Versus Host Disease (GvHD) Sales and Growth Rate (2018-2023)
Figure Germany Graft Versus Host Disease (GvHD) Revenue (Million $) and Growth Rate (2018-2023)
Figure UK Graft Versus Host Disease (GvHD) Sales and Growth Rate (2018-2023)
Figure UK Graft Versus Host Disease (GvHD) Revenue (Million $) and Growth Rate (2018-2023)
Figure France Graft Versus Host Disease (GvHD) Sales and Growth Rate (2018-2023)
Figure France Graft Versus Host Disease (GvHD) Revenue (Million $) and Growth Rate (2018-2023)
Figure Italy Graft Versus Host Disease (GvHD) Sales and Growth Rate (2018-2023)
Figure Italy Graft Versus Host Disease (GvHD) Revenue (Million $) and Growth Rate (2018-2023)
Figure Spain Graft Versus Host Disease (GvHD) Sales and Growth Rate (2018-2023)
Figure Spain Graft Versus Host Disease (GvHD) Revenue (Million $) and Growth Rate (2018-2023)
Figure Russia Graft Versus Host Disease (GvHD) Sales and Growth Rate (2018-2023)
Figure Russia Graft Versus Host Disease (GvHD) Revenue (Million $) and Growth Rate (2018-2023)
Table Asia-Pacific Graft Versus Host Disease (GvHD) Sales by Country (2018-2023)
Figure Asia-Pacific Graft Versus Host Disease (GvHD) Sales Market Share by Country (2018-2023)
Table Asia-Pacific Graft Versus Host Disease (GvHD) Revenue by Country (2018-2023)
Figure Asia-Pacific Graft Versus Host Disease (GvHD) Revenue Market Share by Country (2018-2023)
Figure Asia-Pacific Graft Versus Host Disease (GvHD) Market Share by Type in 2023
Figure Asia-Pacific Graft Versus Host Disease (GvHD) Market Share by Application in 2023
Figure China Graft Versus Host Disease (GvHD) Sales and Growth Rate (2018-2023)
Figure China Graft Versus Host Disease (GvHD) Revenue (Million $) and Growth Rate (2018-2023)
Figure Japan Graft Versus Host Disease (GvHD) Sales and Growth Rate (2018-2023)
Figure Japan Graft Versus Host Disease (GvHD) Revenue (Million $) and Growth Rate (2018-2023)
Figure Korea Graft Versus Host Disease (GvHD) Sales and Growth Rate (2018-2023)
Figure Korea Graft Versus Host Disease (GvHD) Revenue (Million $) and Growth Rate (2018-2023)
Figure India Graft Versus Host Disease (GvHD) Sales and Growth Rate (2018-2023)
Figure India Graft Versus Host Disease (GvHD) Revenue (Million $) and Growth Rate (2018-2023)
Figure Southeast Asia Graft Versus Host Disease (GvHD) Sales and Growth Rate (2018-2023)
Figure Southeast Asia Graft Versus Host Disease (GvHD) Revenue (Million $) and Growth Rate (2018-2023)
Figure Australia Graft Versus Host Disease (GvHD) Sales and Growth Rate (2018-2023)
Figure Australia Graft Versus Host Disease (GvHD) Revenue (Million $) and Growth Rate (2018-2023)
Table South America Graft Versus Host Disease (GvHD) Sales by Country (2018-2023)
Figure South America Graft Versus Host Disease (GvHD) Sales Market Share by Country (2018-2023)
Table South America Graft Versus Host Disease (GvHD) Revenue by Country (2018-2023)
Figure South America Graft Versus Host Disease (GvHD) Revenue Market Share by Country (2018-2023)
Figure South America Graft Versus Host Disease (GvHD) Market Share by Type in 2023
Figure South America Graft Versus Host Disease (GvHD) Market Share by Application in 2023
Figure Brazil Graft Versus Host Disease (GvHD) Sales and Growth Rate (2018-2023)
Figure Brazil Graft Versus Host Disease (GvHD) Revenue (Million $) and Growth Rate (2018-2023)
Figure Mexico Graft Versus Host Disease (GvHD) Sales and Growth Rate (2018-2023)
Figure Mexico Graft Versus Host Disease (GvHD) Revenue (Million $) and Growth Rate (2018-2023)
Figure Argentina Graft Versus Host Disease (GvHD) Sales and Growth Rate (2018-2023)
Figure Argentina Graft Versus Host Disease (GvHD) Revenue (Million $) and Growth Rate (2018-2023)
Figure Colombia Graft Versus Host Disease (GvHD) Sales and Growth Rate (2018-2023)
Figure Colombia Graft Versus Host Disease (GvHD) Revenue (Million $) and Growth Rate (2018-2023)
Table Middle East & Africa Graft Versus Host Disease (GvHD) Sales by Country (2018-2023)
Figure Middle East & Africa Graft Versus Host Disease (GvHD) Sales Market Share by Country (2018-2023)
Table Middle East & Africa Graft Versus Host Disease (GvHD) Revenue by Country (2018-2023)
Figure Middle East & Africa Graft Versus Host Disease (GvHD) Revenue Market Share by Country (2018-2023)
Figure Middle East & Africa Graft Versus Host Disease (GvHD) Market Share by Type in 2023
Figure Middle East & Africa Graft Versus Host Disease (GvHD) Market Share by Application in 2023
Figure Turkey Graft Versus Host Disease (GvHD) Sales and Growth Rate (2018-2023)
Figure Turkey Graft Versus Host Disease (GvHD) Revenue (Million $) and Growth Rate (2018-2023)
Figure UAE Graft Versus Host Disease (GvHD) Sales and Growth Rate (2018-2023)
Figure UAE Graft Versus Host Disease (GvHD) Revenue (Million $) and Growth Rate (2018-2023)
Figure Saudi Arabia Graft Versus Host Disease (GvHD) Sales and Growth Rate (2018-2023)
Figure Saudi Arabia Graft Versus Host Disease (GvHD) Revenue (Million $) and Growth Rate (2018-2023)
Figure South Africa Graft Versus Host Disease (GvHD) Sales and Growth Rate (2018-2023)
Figure South Africa Graft Versus Host Disease (GvHD) Revenue (Million $) and Growth Rate (2018-2023)
Table Company Snapshot of Pfizer
Table Graft Versus Host Disease (GvHD) Introduction of Pfizer
Table Graft Versus Host Disease (GvHD) Sales, Price, Revenue, Gross Margin and Market Share of Pfizer (2021-2023)
Table Industrial Chain of Graft Versus Host Disease (GvHD)
Table Leading Consumers of Graft Versus Host Disease (GvHD)
Figure Global Graft Versus Host Disease (GvHD) Sales and Growth Rate Forecast (2024-2032)
Figure Global Graft Versus Host Disease (GvHD) Revenue and Growth Rate Forecast (2024-2032)
Table Global Graft Versus Host Disease (GvHD) Market Size and CAGR Forecast by Region (2024-2032)
Table Global Graft Versus Host Disease (GvHD) Market Size and CAGR Forecast by Type (2024-2032)
Table Global Graft Versus Host Disease (GvHD) Market Size and CAGR Forecast by Application (2024-2032)
Table Global Graft Versus Host Disease (GvHD) Market Size and CAGR Forecast by Sales Channel (2024-2032)
